公司资料
Sophia Genetics 股价、新闻与催化剂
- 股票代码:
- SOPH
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- Switzerland
股票表现
8.65 USD (+3.84%)
收盘价
最后更新: 2026年8月21日
355M USD
市值
股价为何变动
As of Aug 21, 2026, SOPH closed up 3.84% at $8.65. No new same-company headline was identified in the current news window.
公司概览
业务概览
Sophia Genetics is a healthcare technology company focused on data-driven diagnostics and clinical decision support. Its business is centered on applying software to genomic and pathology workflows.
所在地与行业分类
Headquartered in Switzerland and listed on NASDAQ as an ADR, Sophia Genetics sits in healthcare data and diagnostics.
商业模式特征
The company depends on software adoption, diagnostics workflows, and the value of its data platform across hospitals and labs.
生物医药行业定位
Sophia Genetics is outside biotech proper and belongs to the diagnostics software layer.
未来催化剂
- SOPHiA Genetics’s catalysts are DDM platform adoption, companion-diagnostic partnerships, and recurring software revenue. The business improves when the analytics workflow becomes more embedded in clinical and biopharma use cases.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。